*BioCryst Pharma to Obtain Astria's Early-Stage Program for Atopic Dermatitis, STAR-0310; Co Plans to Seek Strategic Alternatives for This Asset >BCRX

Dow Jones · 10/14/2025 11:05

Please log in to view news